DIA435.72-5.61 -1.27%
SPX6,238.01-101.38 -1.60%
IXIC20,650.13-472.32 -2.24%

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga·07/16/2025 17:06:26
Listen to the news

Gainers

  • Aptorum Group (NASDAQ:APM) stock increased by 252.7% to $3.42 during Wednesday's regular session. The company's market cap stands at $6.9 million.
  • Nuwellis (NASDAQ:NUWE) stock increased by 121.17% to $15.25. The market value of their outstanding shares is at $30.1 million.
  • Barinthus Biotherapeutics (NASDAQ:BRNS) stock moved upwards by 96.18% to $2.0. The company's market cap stands at $41.1 million.
  • Cue Biopharma (NASDAQ:CUE) shares rose 27.14% to $0.89. The market value of their outstanding shares is at $52.7 million.
  • Generation Bio (NASDAQ:GBIO) shares rose 26.46% to $0.54. The market value of their outstanding shares is at $28.5 million.
  • SS Innovations (NASDAQ:SSII) shares increased by 24.95% to $6.66. The market value of their outstanding shares is at $1.0 billion.

Losers

  • ZyVersa Therapeutics (NASDAQ:ZVSA) shares decreased by 33.8% to $0.36 during Wednesday's regular session. The market value of their outstanding shares is at $2.6 million.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock declined by 29.93% to $8.64. The market value of their outstanding shares is at $19.5 million.
  • Celularity (NASDAQ:CELU) stock declined by 15.13% to $2.1. The market value of their outstanding shares is at $59.3 million.
  • Ardent Health (NYSE:ARDT) stock declined by 13.44% to $12.05. The company's market cap stands at $1.9 billion.
  • Onconetix (NASDAQ:ONCO) stock declined by 12.21% to $3.98. The market value of their outstanding shares is at $2.3 million.
  • Silexion Therapeutics (NASDAQ:SLXN) stock declined by 11.83% to $0.67. The company's market cap stands at $6.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.